Literature DB >> 6532481

The role of digitalis in the future.

P A Poole-Wilson.   

Abstract

Cardiac glycosides exert an acute positive inotropic effect on the normal and failing heart. Recent evidence establishes that the positive inotropic effect is maintained over several months in many patients. The effectiveness of long-term treatment with cardiac glycosides in relieving symptoms is less certain; only a small subset of patients benefits. An effect on mortality is not established. The use of digoxin in the treatment of mild heart failure is questionable since the drug has serious side-effects and the efficacy in patients already taking diuretics has not been established. The use of glycosides in the treatment of severe chronic heart failure is being challenged because of the availability of powerful diuretics, new vasodilators and alternative positive inotropes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532481      PMCID: PMC1463482          DOI: 10.1111/j.1365-2125.1984.tb02592.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

1.  Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations.

Authors:  N H Carliner; C A Gilbert; A W Pruitt; L I Goldberg
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

Review 2.  Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

3.  The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+- ATPase or erythrocytes.

Authors:  M Cumberbatch; K Zareian; C Davidson; D B Morgan; R Swaminathan
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

4.  Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure.

Authors:  H DeMots; S H Rahimtoola; J H McAnulty; G A Porter
Journal:  Am J Cardiol       Date:  1978-01       Impact factor: 2.778

5.  Digitalis-associated cardiac mortality after myocardial infarction.

Authors:  A J Moss; H T Davis; D L Conard; J J DeCamilla; C L Odoroff
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

6.  The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J G Carver
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

7.  Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.

Authors:  R J Hoeschen; T E Cuddy
Journal:  Am J Cardiol       Date:  1975-04       Impact factor: 2.778

8.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors:  S M Dobbs; W I Kenyon; R J Dobbs
Journal:  Br Med J       Date:  1977-03-19

9.  Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.

Authors:  J R Dawson; R Canepa-Anson; P Kuan; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-09

10.  Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

Authors:  C S Liang; L G Sherman; J U Doherty; K Wellington; V W Lee; W B Hood
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

View more
  3 in total

Review 1.  Drug treatment of heart failure.

Authors:  P A Poole-Wilson
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  The future role of inotropic drugs.

Authors:  P A Poole-Wilson
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older.

Authors:  W Kruse; J Rampmaier; C Frauenrath-Volkers; D Volkert; I Wankmüller; W Micol; P Oster; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.